WO2016045415A1 - Method for asymmetrically catalyzed synthesis of nitropyrazole amide compound - Google Patents

Method for asymmetrically catalyzed synthesis of nitropyrazole amide compound Download PDF

Info

Publication number
WO2016045415A1
WO2016045415A1 PCT/CN2015/081341 CN2015081341W WO2016045415A1 WO 2016045415 A1 WO2016045415 A1 WO 2016045415A1 CN 2015081341 W CN2015081341 W CN 2015081341W WO 2016045415 A1 WO2016045415 A1 WO 2016045415A1
Authority
WO
WIPO (PCT)
Prior art keywords
amide compound
reaction
rare earth
earth metal
otf
Prior art date
Application number
PCT/CN2015/081341
Other languages
French (fr)
Chinese (zh)
Inventor
冯小明
姚乾
刘小华
林丽丽
张宇恒
Original Assignee
浙江九洲药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201410486209.3A external-priority patent/CN104262255A/en
Application filed by 浙江九洲药业股份有限公司 filed Critical 浙江九洲药业股份有限公司
Priority to EP15844037.0A priority Critical patent/EP3199525A4/en
Priority to JP2017512956A priority patent/JP2017530956A/en
Priority to US15/511,243 priority patent/US10464899B2/en
Publication of WO2016045415A1 publication Critical patent/WO2016045415A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/53Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/2672-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the invention relates to a method for synthesizing ⁇ -nitropyrazole amide by asymmetric Michael addition reaction of ⁇ , ⁇ -unsaturated pyrazole amide with nitroalkane by chiral amine oxide-rare earth metal complex.
  • the ⁇ -nitropyrazole amide compound plays an important role in organic synthesis. It can not only undergo methyl esterification reaction with methanol under the catalysis of alkali, but also has simple operation, high synthesis efficiency, and can be converted into a simple chemical reaction. Biologically active compounds such as ⁇ -amino acid, 2-pyridone, and 2-pyrrolidone. There have been some reports of asymmetric catalytic synthesis of ⁇ -nitropyrazole amide.
  • Carlos F. Barbas III and others used the thiourea derivative XIV as a chiral catalyst and chloroform as a solvent to achieve the asymmetric Michael addition reaction of the following nitroene with pyrazole amide at -20 ° C.
  • the product obtained 34%- 99% yield, dr value of 10:1->20:1 (dr value: diastereoselectivity of compounds containing two or more chiral centers) and ee value of 78%-97% (Angew. Chem. Int. Ed. 2012, 51, 5381).
  • the reaction in the catalytic reaction system of Carlos F. Barbas III, the reaction must be carried out at -20 ° C, which consumes a lot of energy; in the catalytic reaction system of Long Lu, the ⁇ , ⁇ -unsaturated amide extended substrate is The terminal has a trifluoromethyl substitution, and the restriction is relatively large; in the catalytic reaction system of Shuji Kanemasa, it needs to be activated at -78 °C before the reaction, and the reaction temperature of 11 substrates in the extended 16 substrates is -20.
  • the object of the present invention is to develop a Michael addition reaction of an asymmetrically catalyzed ⁇ , ⁇ -unsaturated pyrazole amide compound with a nitroalkane to provide an efficient, simple, energy-saving and environment-friendly synthetic ⁇ -nitropyrazole.
  • a method of an amide compound is to develop a Michael addition reaction of an asymmetrically catalyzed ⁇ , ⁇ -unsaturated pyrazole amide compound with a nitroalkane.
  • the invention provides a method for asymmetrically synthesizing a ⁇ -nitropyrazole amide compound, characterized in that a nitroalkane and an ⁇ , ⁇ -unsaturated pyrazole amide are used as raw materials, and a chiral amine oxide and a rare earth metal are used.
  • the complex formed by the compound is a catalyst,
  • the molecular sieve is an additive, and a chiral ⁇ -nitropyrazole amide compound is obtained, wherein:
  • the structure of the ⁇ , ⁇ -unsaturated pyrazole amide compound is:
  • the ⁇ -nitropyrazole amide compound has the following structure:
  • R, R 1 , R 2 , R 3 have the same definitions as defined above.
  • the structure of the chiral amine oxide ligand is:
  • n 1,2;
  • R Ph-,2,6-Me 2 C 6 H 3 -,2,6-Et 2 C 6 H 3 -,2,6-iPr 2 C 6 H 3 -,Ph 2 CH -;
  • the reaction solvent is selected from the group consisting of alkanes such as pentane, hexane, heptane, etc.; halogenated hydrocarbons such as dichloroethane, chloroform, etc.; aromatic hydrocarbons such as toluene, ethylbenzene, cumene; ethers For example, tetrahydrofuran, methyl tert-butyl ether, 2-methyltetrahydrofuran, etc., esters such as ethyl acetate, isopropyl acetate and the like.
  • alkanes such as pentane, hexane, heptane, etc.
  • halogenated hydrocarbons such as dichloroethane, chloroform, etc.
  • aromatic hydrocarbons such as toluene, ethylbenzene, cumene
  • ethers For example, tetrahydrofuran, methyl tert-butyl
  • the reaction temperature is 25-50 °C.
  • the solution of the present invention is: a method for asymmetrically synthesizing a ⁇ -nitropyrazole amide compound, characterized by using a nitroalkane and an ⁇ , ⁇ -unsaturated pyrazole amide as a raw material, a chiral amine oxide a complex formed with a rare earth metal compound is a catalyst,
  • the molecular sieve is an additive
  • dichloromethane is used as a solvent
  • the reaction is carried out at 25-50 ° C under normal pressure for 12-120 h to obtain a chiral ⁇ -nitropyrazole amide compound.
  • the rare earth metal compound is: bismuth triflate [Gd(OTf) 3 ], bismuth triflate [Sc(OTf) 3 ], bismuth triflate [Ho(OTf) 3 ], trifluoromethyl Sulfonium sulfonate [Yb(OTf) 3 ], ytterbium triflate [Er(OTf) 3 ], yttrium triflate [Y(OTf) 3 ];
  • the molar ratio of the nitroalkane to the ⁇ , ⁇ -unsaturated pyrazole amide compound is 1.86:1-55.8:1, and the optimum molar ratio is 9.3:1.
  • the molar ratio of chiral amine oxide to rare earth metal compound is 0.8:1.0-1.5:1.0, and the optimum molar ratio is 1.2:1.0;
  • the molecular sieve was activated at 450 ° C for 3 hours, corresponding to 0.1 mmol of ⁇ , ⁇ -unsaturated pyrazole amide.
  • the molecular sieve amount is 10-100 mg;
  • Dichloromethane was dried by refluxing with GaH 2 , and the corresponding amount of 0.1 mmol of ⁇ , ⁇ -unsaturated pyrazole amide was 6.2 mmol;
  • the reaction temperature is 30 ° C;
  • the reaction time is 72-96 h.
  • ⁇ -nitropyrazole amide compound prepared by the above method is reacted with methanol in the presence of an organic base to obtain an esterified product.
  • the esterification product has the following structure:
  • R, R 1 have the same definitions as before.
  • the organic base is selected from the group consisting of triethylamine, diisopropylethylamine, trimethylamine, tri-n-propylamine, tri-n-butylamine, dimethylaniline, diethylaniline, dimethylbenzylamine, diethylbenzylamine. 1,8-diazahetero[5,4,0]undecene-7 (DBU).
  • DBU 1,8-diazahetero[5,4,0]undecene-7
  • the present invention has the following outstanding advantages:
  • the operation is simple, the catalyst does not need to be activated, and the product is easily separated from the catalyst, the additive and the raw material.
  • reaction conversion rate and enantioselectivity are high, the reaction yield is as high as 99%, and the enantioselectivity is as high as 99% ee.
  • reaction system is simple and clean, and no acid or alkali additives are needed.
  • the reaction conditions are mild and the reaction is carried out at a normal pressure of 30 °C.
  • the amount of nitroalkane is small, saving raw materials.
  • Example 1 Chiral amine oxide and rare earth metal complex catalyzed Michael addition reaction of asymmetric ⁇ , ⁇ -unsaturated pyrazole amide with nitroalkane
  • a rare earth metal compound No. 1-11: 0.01 mmol, No. 12-16: 0.0075 mmol
  • a chiral amine oxide ligand No. 1-11: 0.012 mmol, serial number 12-16: 0.009 mmol
  • ⁇ , ⁇ -unsaturated pyrazole amide 1a 0.1 mmol
  • Molecular sieve 30mg stirrer, after replacing nitrogen for 3 times, add dichloromethane (6.2mmol), nitromethane (No. 1-11: 5.6mmol, serial number 12-16: 0.93mmol), stir at 25-50 ° C for 12-120h .
  • the reaction was monitored by TLC.
  • Example 2 Chiral amine oxide L6-Gd(OTf) 3 complex catalyzes the Michael addition reaction of asymmetric ⁇ , ⁇ -unsaturated pyrazole amide with nitroalkane
  • Gd(OTf) 3 No. 1-16, 20-23, 25-27: 0.0075 mmol, No. 17-19, 24: 0.01 mmol
  • chiral amine oxide L6 No. 1-16, 20
  • the molar ratio of chiral amine oxide L6 to ytterbium triflate (Gd(OTf) 3 ) is 1.2:1.0
  • ⁇ , ⁇ -unsaturated amide 0.1 mmol
  • Molecular sieve No.
  • Example 3 Michael addition reaction of asymmetric ⁇ , ⁇ -unsaturated pyrazole amide with nitroalkane catalyzed by chiral amine oxide and rare earth metal complex
  • a rare earth metal compound No. 1-11: 0.01 mmol, No. 12-16: 0.0075 mmol
  • a chiral amine oxide ligand No. 1-11: 0.012 mmol, serial number 12-16: 0.009 mmol
  • ⁇ , ⁇ -unsaturated pyrazole amide 1a 0.1 mmol
  • Molecular sieve 30mg stirrer, after replacing nitrogen for 3 times, add dichloromethane (6.2mmol), nitromethane (No. 1-11: 5.6mmol, serial number 12-16: 0.93mmol), stir at 25-50 ° C for 12-120h .
  • the reaction was monitored by TLC.
  • 5a and 5b can synthesize drug molecules, baclofen and paroxetine, according to methods reported in the literature (Org. Lett. 2012, 14, 1516).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A method for asymmetrically catalyzed synthesis of a γ-nitropyrazole amide compound, where a nitroalkene and an α,β-unsaturated pyrazole amide are employed as raw materials, a complex formed by a chiral amine oxide and a rare earth metal compound serves as a catalyst, a 4 Å molecular sieve serves as an additive, and the γ-nitropyrazole amide compound is produced after a reaction, which has a yield as high as 99% and an enantiomeric excess as high as 99% ee. The catalytic system not only has the advantages of a simple operation, mild reaction conditions, not requiring any acidic/basic additive, convenient product purification, high yield and enatioselectivity, compliance with green atomic economy, and great prospects for industrial application, but also allows the γ-nitropyrazole amide compound produced via the reaction to undergo some simple chemical conversions to produce some molecules having physiological activities.

Description

一种不对称催化合成硝基吡唑酰胺化合物的方法Method for asymmetrically catalyzing synthesis of nitropyrazole amide compound
本申请要求于2014年9月22日提交中国专利局、申请号为201410486209.3、发明名称为“一种不对称催化合成γ-硝基吡唑酰胺化合物的方法”,于2015年2月12日提交中国专利局、申请号为201510075076.5、发明名称为“一种不对称催化合成γ-硝基吡唑酰胺化合物的方法”的两项中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application is submitted to the Chinese Patent Office on September 22, 2014, the application number is 201410486209.3, and the invention is entitled “A method for asymmetric catalytic synthesis of γ-nitropyrazole amide compounds”, which was submitted on February 12, 2015. Priority of the Chinese Patent Office, Application No. 201510075076.5, entitled "A Method for Asymmetric Catalytic Synthesis of γ-Nitropyrazolamide Compounds", the entire contents of which are incorporated herein by reference. .
技术领域Technical field
本发明涉及手性氧化胺-稀土金属络合物催化α,β-不饱和吡唑酰胺与硝基烷烃的不对称Michael加成反应合成γ-硝基吡唑酰胺的方法。The invention relates to a method for synthesizing γ-nitropyrazole amide by asymmetric Michael addition reaction of α,β-unsaturated pyrazole amide with nitroalkane by chiral amine oxide-rare earth metal complex.
背景技术Background technique
γ-硝基吡唑酰胺化合物在有机合成中占有很重要的地位,它不但可以在碱的催化下与甲醇发生甲酯化反应,操作简单,合成效率高,还可以通过简单的化学反应转化为γ-氨基酸、2-吡啶酮以及2-吡咯烷酮等具有生物活性的化合物。目前已有一些不对称催化合成γ-硝基吡唑酰胺的报道。The γ-nitropyrazole amide compound plays an important role in organic synthesis. It can not only undergo methyl esterification reaction with methanol under the catalysis of alkali, but also has simple operation, high synthesis efficiency, and can be converted into a simple chemical reaction. Biologically active compounds such as γ-amino acid, 2-pyridone, and 2-pyrrolidone. There have been some reports of asymmetric catalytic synthesis of γ-nitropyrazole amide.
Carlos F.Barbas III等利用硫脲衍生物XIV为手性催化剂,氯仿为溶剂,在-20℃下实现了下列硝基烯与吡唑酰胺的不对称Michael加成反应,产物可获得34%-99%的收率、10:1->20:1的d.r值(d.r值:含有两个及以上手性中心的化合物的非对映选择性)和78%-97%的ee值(Angew.Chem.Int.Ed.2012,51,5381)。Carlos F. Barbas III and others used the thiourea derivative XIV as a chiral catalyst and chloroform as a solvent to achieve the asymmetric Michael addition reaction of the following nitroene with pyrazole amide at -20 ° C. The product obtained 34%- 99% yield, dr value of 10:1->20:1 (dr value: diastereoselectivity of compounds containing two or more chiral centers) and ee value of 78%-97% (Angew. Chem. Int. Ed. 2012, 51, 5381).
Figure PCTCN2015081341-appb-000001
Figure PCTCN2015081341-appb-000001
Long Lu等利用硫脲衍生物2d为手性催化剂,甲苯为溶剂,在室温下实现了下列硝基烷烃与三氟甲基取代的吡唑酰胺的不对称Michael加成反应,产物可获得71%-91%的收率、4.4:1–9.9:1的d.r值(d.r值:含有两个及以上手性中心的化合物的非对映选择性)和80%-93%的ee值(ACS Catal.2013,3,502)。 Long Lu et al. used the thiourea derivative 2d as a chiral catalyst and toluene as a solvent to achieve asymmetric Michael addition reaction of the following nitroalkane with trifluoromethyl substituted pyrazole amide at room temperature. -91% yield, dr value of 4.4:1 - 9.9:1 (dr value: diastereoselectivity of compounds containing two or more chiral centers) and ee values of 80%-93% (ACS Catal .2013, 3, 502).
Figure PCTCN2015081341-appb-000002
Figure PCTCN2015081341-appb-000002
Shuji Kanemasa等利用R,R-DBFOX/Ph*Ni(ClO4)2*3H2O(A)和2,2,6,6-tetramethylpiperidine(TMP)作为组合催化剂,硝基甲烷与四氢呋喃(v/v=1/1)为混合溶剂,在-20℃至室温下实现了下列硝基甲烷对不饱和吡唑酰胺的不对称Michael加成反应,产物可获得39%-97%的收率和77%-97%的ee值(J.Am.Chem.Soc.2002,124,13394)。Shuji Kanemasa et al. used R, R-DBFOX/Ph * Ni(ClO 4 ) 2* 3H 2 O(A) and 2,2,6,6-tetramethylpiperidine (TMP) as a combined catalyst, nitromethane and tetrahydrofuran (v/ v=1/1) is a mixed solvent, and the following asymmetric addition reaction of nitromethane to unsaturated pyrazole amide is achieved at -20 ° C to room temperature, and the product can obtain a yield of 39%-97% and 77. An ee value of %-97% (J. Am. Chem. Soc. 2002, 124, 13394).
Figure PCTCN2015081341-appb-000003
Figure PCTCN2015081341-appb-000003
综上所述,Carlos F.Barbas III的催化反应体系中,反应须在-20℃进行,会耗费很多能量;Long Lu的催化反应体系中,α,β-不饱和酰胺扩展的底物都是端位有三氟甲基取代的,限制比较大;Shuji Kanemasa的催化反应体系中,反应前需要在-78℃活化,并且扩展的16个底物中,有11个底物的反应温度为-20℃,3个底物需要0℃,仅仅只有两个底物可以在室温下反应,有11个底物的反应时间需要96h,其中有6个底物反应时间需要168h,并且收率也并不理想,反应完成后需先用饱和氯化铵洗涤产品后才柱层析分离纯化,反应条件苛刻,操作复杂,硝基甲烷的用量太大(0.1mmolα,β-不饱和吡唑酰胺化合物需要用9.1mmol硝基甲烷),最重要的是所得的反应结果并不好。所以一种高效、操作简单、节约能源并利于环境的方法亟需被发展。In summary, in the catalytic reaction system of Carlos F. Barbas III, the reaction must be carried out at -20 ° C, which consumes a lot of energy; in the catalytic reaction system of Long Lu, the α,β-unsaturated amide extended substrate is The terminal has a trifluoromethyl substitution, and the restriction is relatively large; in the catalytic reaction system of Shuji Kanemasa, it needs to be activated at -78 °C before the reaction, and the reaction temperature of 11 substrates in the extended 16 substrates is -20. °C, 3 substrates need 0 °C, only two substrates can be reacted at room temperature, the reaction time of 11 substrates needs 96h, 6 substrates need 168h reaction time, and the yield is not Ideally, after the reaction is completed, the product is washed with saturated ammonium chloride and then separated and purified by column chromatography. The reaction conditions are harsh, the operation is complicated, and the amount of nitromethane is too large (0.1 mmol α, β-unsaturated pyrazole amide compound is needed) 9.1 mmol nitromethane), the most important thing is that the reaction results obtained are not good. Therefore, an efficient, simple operation, energy-saving and environmentally friendly approach needs to be developed.
发明内容Summary of the invention
本发明的目的是发展不对称催化α,β-不饱和吡唑酰胺化合物与硝基烷烃的Michael加成反应,提供一种高效、操作简单、节约能源并利于环境的合成γ-硝基吡唑酰胺化合物的方法。The object of the present invention is to develop a Michael addition reaction of an asymmetrically catalyzed α,β-unsaturated pyrazole amide compound with a nitroalkane to provide an efficient, simple, energy-saving and environment-friendly synthetic γ-nitropyrazole. A method of an amide compound.
本发明的方案是:一种不对称催化合成γ-硝基吡唑酰胺化合物的方法,其特征在于以硝基烷烃和α,β-不饱和吡唑酰胺为原料,手性氧化胺与稀土金属化合物形成的络合物为催化剂,
Figure PCTCN2015081341-appb-000004
分子筛为添加剂,得手性γ-硝基吡唑酰胺化合物,其中:
The invention provides a method for asymmetrically synthesizing a γ-nitropyrazole amide compound, characterized in that a nitroalkane and an α,β-unsaturated pyrazole amide are used as raw materials, and a chiral amine oxide and a rare earth metal are used. The complex formed by the compound is a catalyst,
Figure PCTCN2015081341-appb-000004
The molecular sieve is an additive, and a chiral γ-nitropyrazole amide compound is obtained, wherein:
硝基烷烃的结构为RCH2NO2,R=H,CH3,Et,Bn;The structure of the nitroalkane is RCH 2 NO 2 , R=H, CH 3 , Et, Bn;
α,β-不饱和吡唑酰胺化合物的结构为: The structure of the α,β-unsaturated pyrazole amide compound is:
Figure PCTCN2015081341-appb-000005
Figure PCTCN2015081341-appb-000005
R1=C6H5,4-FC6H4,4-ClC6H4,4-BrC6H4,4-MeC6H4,4-MeOC6H4,3-BrC6H4,3-MeC6H4,2-BrC6H4,2-MeOC6H4,3,4–Cl2C6H3,3,4-(MeO)2C6H3,2-Furyl,2-Thienyl,CH3,Pr,Pent,iBu,EtO,EtOOC;R2=CH3,Ph;R3=H,Cl,Br,I;R 1 =C 6 H 5 ,4-FC 6 H 4 ,4-ClC 6 H 4 ,4-BrC 6 H 4 ,4-MeC 6 H 4 ,4-MeOC 6 H 4 ,3-BrC 6 H 4 , 3-MeC 6 H 4 ,2-BrC 6 H 4 ,2-MeOC 6 H 4 ,3,4–Cl 2 C 6 H 3 ,3,4-(MeO) 2 C 6 H 3 ,2-Furyl,2 -Thienyl, CH 3 , Pr, Pent, i Bu, EtO, EtOOC; R 2 =CH 3 , Ph; R 3 =H, Cl, Br, I;
γ-硝基吡唑酰胺化合物具有如下结构:The γ-nitropyrazole amide compound has the following structure:
Figure PCTCN2015081341-appb-000006
Figure PCTCN2015081341-appb-000006
其中R,R1,R2,R3的定义与上文定义相同。Wherein R, R 1 , R 2 , R 3 have the same definitions as defined above.
手性氧化胺配体的结构为:The structure of the chiral amine oxide ligand is:
Figure PCTCN2015081341-appb-000007
Figure PCTCN2015081341-appb-000007
n=1,2;R=Ph-,2,6-Me2C6H3-,2,6-Et2C6H3-,2,6-iPr2C6H3-,Ph2CH-;n=1,2; R=Ph-,2,6-Me 2 C 6 H 3 -,2,6-Et 2 C 6 H 3 -,2,6-iPr 2 C 6 H 3 -,Ph 2 CH -;
所述的反应溶剂选自烷烃类,如戊烷、己烷、庚烷等;卤代烃类,如二氯乙烷、氯仿等;芳烃类,如甲苯、乙苯、异丙苯;醚类,如四氢呋喃、甲基叔丁基醚、2-甲基四氢呋喃等,酯类,如乙酸乙酯、乙酸异丙酯等。The reaction solvent is selected from the group consisting of alkanes such as pentane, hexane, heptane, etc.; halogenated hydrocarbons such as dichloroethane, chloroform, etc.; aromatic hydrocarbons such as toluene, ethylbenzene, cumene; ethers For example, tetrahydrofuran, methyl tert-butyl ether, 2-methyltetrahydrofuran, etc., esters such as ethyl acetate, isopropyl acetate and the like.
优选的,反应温度为25-50℃。Preferably, the reaction temperature is 25-50 °C.
优选的,本发明的方案是:一种不对称催化合成γ-硝基吡唑酰胺化合物的方法,其特征在于以硝基烷烃和α,β-不饱和吡唑酰胺为原料,手性氧化胺与稀土金属化合物形成的络合物为催化剂,
Figure PCTCN2015081341-appb-000008
分子筛为添加剂,二氯甲烷为溶剂,于25-50℃,常压下反应12-120h,得手性γ-硝基吡唑酰胺化合物。
Preferably, the solution of the present invention is: a method for asymmetrically synthesizing a γ-nitropyrazole amide compound, characterized by using a nitroalkane and an α,β-unsaturated pyrazole amide as a raw material, a chiral amine oxide a complex formed with a rare earth metal compound is a catalyst,
Figure PCTCN2015081341-appb-000008
The molecular sieve is an additive, dichloromethane is used as a solvent, and the reaction is carried out at 25-50 ° C under normal pressure for 12-120 h to obtain a chiral γ-nitropyrazole amide compound.
上述方法TLC检测反应终点,利用硅胶柱层析分离得到手性γ-硝基吡唑酰胺化合物。The above method was used to detect the end point of the reaction by TLC, and the chiral γ-nitropyrazole amide compound was isolated by silica gel column chromatography.
稀土金属化合物为:三氟甲磺酸钆[Gd(OTf)3]、三氟甲磺酸钪[Sc(OTf)3]、三氟甲磺酸钬[Ho(OTf)3]、三氟甲磺酸镱[Yb(OTf)3]、三氟甲磺酸铒[Er(OTf)3]、三氟甲磺酸钇[Y(OTf)3];The rare earth metal compound is: bismuth triflate [Gd(OTf) 3 ], bismuth triflate [Sc(OTf) 3 ], bismuth triflate [Ho(OTf) 3 ], trifluoromethyl Sulfonium sulfonate [Yb(OTf) 3 ], ytterbium triflate [Er(OTf) 3 ], yttrium triflate [Y(OTf) 3 ];
硝基烷烃与α,β-不饱和吡唑酰胺化合物的摩尔比是1.86:1-55.8:1,最佳摩尔比是9.3:1。 The molar ratio of the nitroalkane to the α,β-unsaturated pyrazole amide compound is 1.86:1-55.8:1, and the optimum molar ratio is 9.3:1.
反应的最佳催化剂是手性氧化胺L6(n=2,R=2,6-iPr2C6H3-)与三氟甲磺酸钆[Gd(OTf)3]形成的络合物,手性氧化胺与稀土金属化合物的摩尔比为0.8:1.0-1.5:1.0,最佳摩尔比是1.2:1.0;The most preferred catalyst for the reaction is a complex of chiral amine oxide L6 (n=2, R=2,6-iPr 2 C 6 H 3 -) with ytterbium triflate [Gd(OTf) 3 ], The molar ratio of chiral amine oxide to rare earth metal compound is 0.8:1.0-1.5:1.0, and the optimum molar ratio is 1.2:1.0;
Figure PCTCN2015081341-appb-000009
分子筛450℃下活化3小时,0.1mmol的α,β-不饱和吡唑酰胺对应的
Figure PCTCN2015081341-appb-000010
分子筛量为10-100mg;
Figure PCTCN2015081341-appb-000009
The molecular sieve was activated at 450 ° C for 3 hours, corresponding to 0.1 mmol of α,β-unsaturated pyrazole amide.
Figure PCTCN2015081341-appb-000010
The molecular sieve amount is 10-100 mg;
二氯甲烷经GaH2回流干燥处理,0.1mmol的α,β-不饱和吡唑酰胺对应的量为6.2mmol;Dichloromethane was dried by refluxing with GaH 2 , and the corresponding amount of 0.1 mmol of α,β-unsaturated pyrazole amide was 6.2 mmol;
反应温度为30℃;The reaction temperature is 30 ° C;
反应时间为72-96h。The reaction time is 72-96 h.
进一步地,经上述方法制备得到的γ-硝基吡唑酰胺化合物在有机碱存在下与甲醇反应得到酯化产物。Further, the γ-nitropyrazole amide compound prepared by the above method is reacted with methanol in the presence of an organic base to obtain an esterified product.
所述的酯化产物具有如下结构:The esterification product has the following structure:
Figure PCTCN2015081341-appb-000011
Figure PCTCN2015081341-appb-000011
其中R,R1的定义与前文相同。Wherein R, R 1 have the same definitions as before.
所述有机碱选自三乙胺,二异丙基乙胺,三甲胺,三正丙胺,三正丁胺,二甲基苯胺,二乙基苯胺,二甲基苄胺,二乙基苄胺,1,8-二氮杂环[5,4,0]十一烯-7(DBU)。The organic base is selected from the group consisting of triethylamine, diisopropylethylamine, trimethylamine, tri-n-propylamine, tri-n-butylamine, dimethylaniline, diethylaniline, dimethylbenzylamine, diethylbenzylamine. 1,8-diazahetero[5,4,0]undecene-7 (DBU).
与背景技术相比,本发明具有如下突出优势:Compared with the background art, the present invention has the following outstanding advantages:
1.操作简便,催化剂不需要活化,产物易与催化剂、添加剂、原料分离。1. The operation is simple, the catalyst does not need to be activated, and the product is easily separated from the catalyst, the additive and the raw material.
2.反应转化率和对映选择性高,反应收率高达99%,对映选择性高达99%ee。2. The reaction conversion rate and enantioselectivity are high, the reaction yield is as high as 99%, and the enantioselectivity is as high as 99% ee.
3.反应体系简单清洁,无需酸、碱添加剂。3. The reaction system is simple and clean, and no acid or alkali additives are needed.
4.反应条件温和,常压30℃下反应。4. The reaction conditions are mild and the reaction is carried out at a normal pressure of 30 °C.
5.硝基烷烃的用量较少,节约原料。5. The amount of nitroalkane is small, saving raw materials.
具体实施方式detailed description
实施例1:手性氧化胺与稀土金属络合物催化不对称α,β-不饱和吡唑酰胺与硝基烷烃的Michael加成反应Example 1: Chiral amine oxide and rare earth metal complex catalyzed Michael addition reaction of asymmetric α,β-unsaturated pyrazole amide with nitroalkane
在反应容器中加入稀土金属化合物(序号1-11:0.01mmol,序号12-16:0.0075mmol)、手性氧化胺配体(序号1-11:0.012mmol,序号12-16:0.009mmol)、α,β-不饱和吡唑酰胺1a (0.1mmol)、
Figure PCTCN2015081341-appb-000012
分子筛30mg、搅拌子,置换氮气3次后加入二氯甲烷(6.2mmol)、硝基甲烷(序号1-11:5.6mmol,序号12-16:0.93mmol),于25-50℃搅拌12-120h。TLC监测反应。柱层析分离纯化,产物的对映体过量用高效液相色谱(Daicel chiralcel IE,V正己烷:V异丙醇=90:10,流速1.0mL/min)测定,见表1。反应式和手性氧化胺配体结构如下:
A rare earth metal compound (No. 1-11: 0.01 mmol, No. 12-16: 0.0075 mmol) and a chiral amine oxide ligand (No. 1-11: 0.012 mmol, serial number 12-16: 0.009 mmol) are added to the reaction vessel. α,β-unsaturated pyrazole amide 1a (0.1 mmol),
Figure PCTCN2015081341-appb-000012
Molecular sieve 30mg, stirrer, after replacing nitrogen for 3 times, add dichloromethane (6.2mmol), nitromethane (No. 1-11: 5.6mmol, serial number 12-16: 0.93mmol), stir at 25-50 ° C for 12-120h . The reaction was monitored by TLC. The column was separated and purified, and the enantiomeric excess of the product was determined by high performance liquid chromatography (Daicel chiralcel IE, V n-hexane : V isopropanol = 90:10, flow rate: 1.0 mL/min), as shown in Table 1. The reactive and chiral amine oxide ligand structures are as follows:
Figure PCTCN2015081341-appb-000013
Figure PCTCN2015081341-appb-000013
表一.手性氧化胺与稀土金属络合物催化不对称α,β-不饱和吡唑酰胺和硝基甲烷的不对称Michael加成反应条件优化(n.d.:未检测)Table 1. Optimization of asymmetric Michael addition conditions for asymmetric α,β-unsaturated pyrazole amide and nitromethane catalyzed by chiral amine oxides and rare earth metal complexes (n.d.: undetected)
Figure PCTCN2015081341-appb-000014
Figure PCTCN2015081341-appb-000014
实施例2:手性氧化胺L6-Gd(OTf)3络合物催化不对称α,β-不饱和吡唑酰胺与硝基烷烃的Michael加成反应Example 2: Chiral amine oxide L6-Gd(OTf) 3 complex catalyzes the Michael addition reaction of asymmetric α,β-unsaturated pyrazole amide with nitroalkane
在反应容器中加入Gd(OTf)3(序号1-16,20-23,25-27:0.0075mmol,序号17-19,24:0.01mmol)、手性氧化胺L6(序号1-16,20-23,25-27:0.009mmol,序号17-19,24:0.012mmol)(手性氧化胺L6与三氟甲磺酸钆(Gd(OTf)3)的摩尔比为1.2:1.0)、α,β-不饱和酰胺(0.1mmol)、
Figure PCTCN2015081341-appb-000015
分子筛(序号1-16,20-27:30mg,序号18:100mg,序号17,19:60mg)、搅拌子,置换氮气3次后加入6.2mmol二氯甲烷和0.93mmol硝基烷烃,30℃下搅拌72h。柱层析分离纯化,产物的对映体过量用手性高效液相色谱测定,反应式如下:
Gd(OTf) 3 (No. 1-16, 20-23, 25-27: 0.0075 mmol, No. 17-19, 24: 0.01 mmol) and chiral amine oxide L6 (No. 1-16, 20) were added to the reaction vessel. -23, 25-27: 0.009 mmol, No. 17-19, 24: 0.012 mmol) (The molar ratio of chiral amine oxide L6 to ytterbium triflate (Gd(OTf) 3 ) is 1.2:1.0), α , β-unsaturated amide (0.1 mmol),
Figure PCTCN2015081341-appb-000015
Molecular sieve (No. 1-16, 20-27: 30mg, serial number 18: 100mg, serial number 17, 19: 60mg), stirrer, after replacing nitrogen for 3 times, add 6.2mmol dichloromethane and 0.93mmol nitroalkane at 30 °C Stir for 72 h. Separation and purification by column chromatography, the enantiomeric excess of the product is determined by chiral high performance liquid chromatography, and the reaction formula is as follows:
Figure PCTCN2015081341-appb-000016
Figure PCTCN2015081341-appb-000016
反应结果见表2:(d.r:含有两个及以上手性中心的化合物的非对映选择性)The reaction results are shown in Table 2: (d.r: diastereoselectivity of compounds containing two or more chiral centers)
表2.手性氧化胺L6-Gd(OTf)3络合物催化不对称α,β-不饱和吡唑酰胺与硝基烷烃的Michael加成反应Table 2. Michael addition reaction of asymmetric α,β-unsaturated pyrazole amide with nitroalkane catalyzed by chiral amine oxide L6-Gd(OTf) 3 complex
序号Serial number R,R1,R2,R3R, R1, R2, R3 收率(%)Yield (%) 对映选择性(%ee)Enantioselectivity (%ee)
11 H,C6H5,CH3,HH, C 6 H 5 , CH 3 , H 9999 9999
22 H,4-FC6H4,CH3,HH,4-FC 6 H 4 ,CH 3 ,H 9999 9999
33 H,4-ClC6H4,CH3,HH,4-ClC 6 H 4 ,CH 3 ,H 9898 9898
44 H,4-BrC6H4,CH3,HH,4-BrC 6 H 4 ,CH 3 ,H 9696 9898
55 H,4-MeC6H4,CH3,HH,4-MeC 6 H 4 ,CH 3 ,H 9595 9999
66 H,4-MeOC6H4,CH3,HH,4-MeOC 6 H 4 ,CH 3 ,H 8989 9999
77 H,3-BrC6H4,CH3,HH,3-BrC 6 H 4 ,CH 3 ,H 9898 9898
88 H,3-MeC6H4,CH3,HH,3-MeC 6 H 4 ,CH 3 ,H 9696 9999
99 H,2-BrC6H4,CH3,HH,2-BrC 6 H 4 ,CH 3 ,H 9999 9999
1010 H,2-MeOC6H4,CH3,HH,2-MeOC 6 H 4 ,CH 3 ,H 9999 9999
1111 H,3,4–Cl2C6H3,CH3,HH,3,4–Cl 2 C 6 H 3 ,CH 3 ,H 9696 9999
1212 H,3,4-(MeO)2C6H3,CH3,HH,3,4-(MeO) 2 C 6 H 3 ,CH 3 ,H 8383 9999
1313 H,2-Furyl,CH3,HH,2-Furyl,CH 3 ,H 5656 9797
1414 H,2-Thienyl,CH3,HH,2-Thienyl, CH 3 , H 5858 9898
1515 H,CH3,CH3,HH, CH 3 , CH 3 , H 6969 9898
1616 H,Pr,CH3,HH, Pr, CH 3 , H 8787 9898
1717 H,Pent,CH3,HH, Pent, CH 3 , H 6565 9898
1818 H,iBu,CH3,HH, i Bu, CH 3 , H 7777 9898
1919 H,EtO,CH3,HH, EtO, CH 3 , H 5353 9595
2020 H,EtOOC,CH3,HH, EtOOC, CH 3 , H 6767 9595
21twenty one H,4-ClC6H4,CH3,ClH,4-ClC 6 H 4 ,CH 3 ,Cl 9494 9999
22twenty two H,4-ClC6H4,CH3,BrH,4-ClC 6 H 4 ,CH 3 ,Br 9696 9999
23twenty three H,4-ClC6H4,CH3,IH,4-ClC 6 H 4 ,CH 3 ,I 9797 9999
24twenty four H,4-ClC6H4,C6H5,HH,4-ClC 6 H 4 ,C 6 H 5 ,H 3939 8181
2525 CH3,4-ClC6H4,CH3,HCH 3 ,4-ClC 6 H 4 ,CH 3 ,H 9494 98/98(d.r.1.6/1)98/98 (d.r.1.6/1)
2626 Et,4-ClC6H4,CH3,HEt,4-ClC 6 H 4 ,CH 3 ,H 8787 99/98(d.r.1.2/1)99/98 (d.r.1.2/1)
2727 PhCH2,4-ClC6H4,CH3,HPhCH 2 ,4-ClC 6 H 4 ,CH 3 ,H 9898 99/98(d.r.1.1/1)99/98 (d.r.1.1/1)
实施例3:手性氧化胺与稀土金属络合物催化不对称α,β-不饱和吡唑酰胺与硝基烷烃的Michael加成反应Example 3: Michael addition reaction of asymmetric α,β-unsaturated pyrazole amide with nitroalkane catalyzed by chiral amine oxide and rare earth metal complex
在反应容器中加入稀土金属化合物(序号1-11:0.01mmol,序号12-16:0.0075mmol)、手性氧化胺配体(序号1-11:0.012mmol,序号12-16:0.009mmol)、α,β-不饱和吡唑酰胺1a(0.1mmol)、
Figure PCTCN2015081341-appb-000017
分子筛30mg、搅拌子,置换氮气3次后加入二氯甲烷(6.2mmol)、硝基甲烷(序号1-11:5.6mmol,序号12-16:0.93mmol),于25-50℃搅拌12-120h。TLC监测反应。柱层析分离纯化,产物的对映体过量用高效液相色谱(Daicel chiralcel IE,V正己烷:V异丙醇=90:10,流速1.0mL/min)测定,见表1。反应式和手性氧化胺配体结构如下:
A rare earth metal compound (No. 1-11: 0.01 mmol, No. 12-16: 0.0075 mmol) and a chiral amine oxide ligand (No. 1-11: 0.012 mmol, serial number 12-16: 0.009 mmol) are added to the reaction vessel. α,β-unsaturated pyrazole amide 1a (0.1 mmol),
Figure PCTCN2015081341-appb-000017
Molecular sieve 30mg, stirrer, after replacing nitrogen for 3 times, add dichloromethane (6.2mmol), nitromethane (No. 1-11: 5.6mmol, serial number 12-16: 0.93mmol), stir at 25-50 ° C for 12-120h . The reaction was monitored by TLC. The column was separated and purified, and the enantiomeric excess of the product was determined by high performance liquid chromatography (Daicel chiralcel IE, V n-hexane : V isopropanol = 90:10, flow rate: 1.0 mL/min), as shown in Table 1. The reactive and chiral amine oxide ligand structures are as follows:
Figure PCTCN2015081341-appb-000018
Figure PCTCN2015081341-appb-000018
表3.手性氧化胺L6-Gd(OTf)3络合物在不同溶剂和温度下催化不对称α,β-不饱和吡唑酰胺与硝基烷烃的Michael加成反应Table 3. Michael addition reaction of asymmetric α,β-unsaturated pyrazole amide with nitroalkane in chiral amine oxide L6-Gd(OTf) 3 complex at different solvents and temperatures
Figure PCTCN2015081341-appb-000019
Figure PCTCN2015081341-appb-000019
Figure PCTCN2015081341-appb-000020
Figure PCTCN2015081341-appb-000020
实施例4:放大量实验1Example 4: Amplification amount experiment 1
在装有磁力搅拌装置的圆底烧瓶中,加入氧化胺配体L6(0.24mmol)、三氟甲磺酸钆(0.2mmol)、序号2中不饱和酰胺(0.976g,4mmol)、
Figure PCTCN2015081341-appb-000021
分子筛1.2g,抽换氮气3次,然后加入186mmol二氯甲烷、37.2mmol硝基甲烷,30℃下搅拌96h。硅胶柱层析分离,得到催化产物为白色固体,1.217g,收率:99%;利用高效液相色谱(Daicel chiralcel IE,V正己烷:V 丙醇=90:10,流速1.0mL/min)测定,得到产物的对映选择性ee值99%。
In a round bottom flask equipped with a magnetic stirring device, an amine oxide ligand L6 (0.24 mmol), ytterbium triflate (0.2 mmol), an unsaturated amide of No. 2 (0.976 g, 4 mmol),
Figure PCTCN2015081341-appb-000021
Molecular sieve 1.2 g, nitrogen gas was exchanged 3 times, then 186 mmol of dichloromethane, 37.2 mmol of nitromethane were added, and stirred at 30 ° C for 96 h. Silica gel column chromatography, to obtain a catalytic product as a white solid, 1.217 g, yield: 99%; by HPLC (Daicel chiralcel IE, V n-hexane: isopropyl alcohol = 90 V: 10, flow rate 1.0mL / min The assay gave an enantioselective ee value of 99% of the product.
实施例5:放大量实验2Example 5: Magnification Experiment 2
在装有磁力搅拌装置的圆底烧瓶中,加入氧化胺配体L6(0.36mmol)、三氟甲磺酸钆(0.3mmol)、序号3中不饱和酰胺(1.04g,4mmol)、
Figure PCTCN2015081341-appb-000022
分子筛1.2g,抽换氮气3次,然后加入186mmol二氯甲烷、37.2mmol硝基甲烷,30℃下搅拌72h。硅胶柱层析分离,得到催化产物为白色固体,1.278g,收率:99%;利用高效液相色谱(Daicel chiralcel IE,V正己烷:V 丙醇=90:10,流速1.0mL/min)测定,得到产物的对映选择性ee值98%。
In a round bottom flask equipped with a magnetic stirring device, an amine oxide ligand L6 (0.36 mmol), ytterbium triflate (0.3 mmol), and an unsaturated amide of No. 3 (1.04 g, 4 mmol) were added.
Figure PCTCN2015081341-appb-000022
Molecular sieve 1.2 g, nitrogen was exchanged 3 times, then 186 mmol of dichloromethane, 37.2 mmol of nitromethane were added, and stirred at 30 ° C for 72 h. Silica gel column chromatography, to obtain a catalytic product as a white solid, 1.278g, yield: 99%; by HPLC (Daicel chiralcel IE, V n-hexane: isopropyl alcohol = 90 V: 10, flow rate 1.0mL / min The assay gave an enantioselective ee value of 98% for the product.
实施例6:放大量实验3Example 6: Magnification Experiment 3
在装有磁力搅拌装置的圆底烧瓶中,加入氧化胺配体L6(0.72mmol)、三氟甲磺酸钆(0.6 mmol)、序号18中不饱和酰胺(1.236g,6mmol)、
Figure PCTCN2015081341-appb-000023
分子筛6.5g,抽换氮气3次,然后加入325.5mmol二氯甲烷、55.8mmol硝基甲烷,30℃下搅拌72h。硅胶柱层析分离,得到催化产物为无色液体,1.34g,收率:83%;利用高效液相色谱(Daicel chiralcel IE,V正己烷:V异丙醇=90:10,流速1.0mL/min)测定,得到产物的对映选择性ee值99%。
In a round bottom flask equipped with a magnetic stirrer, an amine oxide ligand L6 (0.72 mmol), ytterbium triflate (0.6 mmol), an unsaturated amide of No. 18 (1.236 g, 6 mmol),
Figure PCTCN2015081341-appb-000023
Molecular sieve 6.5 g, nitrogen gas was exchanged 3 times, then 325.5 mmol dichloromethane, 55.8 mmol nitromethane was added, and stirred at 30 ° C for 72 h. Separation by silica gel column chromatography gave the product as a colorless liquid, 1.34 g, yield: 83%; using high performance liquid chromatography (Daicel chiralcel IE, V n-hexane : V isopropanol = 90:10, flow rate 1.0 mL / Min) Determination gave the product an enantioselective ee value of 99%.
γ-硝基吡唑酰胺化合物在合成中的应用:Application of γ-nitropyrazole amide compound in synthesis:
实施例7:催化产物的酯化反应Example 7: Esterification of catalytic products
催化反应完成后(起始α,β-不饱和吡唑酰胺为0.1mmol),往盛有3b和3a反应液的试管中分别加入DBU(0.067mmol)和甲醇(2.5mmol),在室温下搅拌过夜。柱层析分离纯化,利用高效液相色谱分析(3a:Daicel chiralcel IB,V正己烷:V异丙醇=90:10,流速1.0mL/min)、(3b:Daicel chiralcel IC,V正己烷:V异丙醇=95:5,流速0.8mL/min)。结果如下:After the completion of the catalytic reaction (starting α,β-unsaturated pyrazole amide is 0.1 mmol), DBU (0.067 mmol) and methanol (2.5 mmol) were added to the tubes containing the reaction solutions of 3b and 3a, respectively, and stirred at room temperature. overnight. Separation and purification by column chromatography, and analyzed by high performance liquid chromatography (3a: Daicel chiralcel IB, V n-hexane : V isopropanol = 90:10, flow rate 1.0 mL/min), (3b: Daicel chiralcel IC, V -hexane : V isopropanol = 95:5, flow rate 0.8 mL/min). The results are as follows:
Figure PCTCN2015081341-appb-000024
Figure PCTCN2015081341-appb-000024
5a和5b可以按照文献报道的方法合成药物分子,巴氯芬和帕罗西汀(Org.Lett.2012,14,1516)。5a and 5b can synthesize drug molecules, baclofen and paroxetine, according to methods reported in the literature (Org. Lett. 2012, 14, 1516).
催化反应完成后(起始α,β-不饱和吡唑酰胺为0.1mmol),往盛有3b反应液的试管中分别加入三乙胺(0.067mmol)和甲醇(2.5mmol),在室温下搅拌过夜。柱层析分离纯化,利用高效液相色谱分析(3a:Daicel chiralcel IB,V正己烷:V异丙醇=90:10,流速1.0mL/min)、(3b:Daicel chiralcel IC,V正己烷:V异丙醇=95:5,流速0.8mL/min),得到(S)-5b,94.2%收率,99%ee。After the completion of the catalytic reaction (starting α,β-unsaturated pyrazole amide is 0.1 mmol), triethylamine (0.067 mmol) and methanol (2.5 mmol) were separately added to the tube containing the 3b reaction solution, and stirred at room temperature. overnight. Separation and purification by column chromatography, and analyzed by high performance liquid chromatography (3a: Daicel chiralcel IB, V n-hexane : V isopropanol = 90:10, flow rate 1.0 mL/min), (3b: Daicel chiralcel IC, V -hexane : V isopropanol = 95:5, flow rate 0.8 mL/min) gave (S)-5b, 94.2% yield, 99% ee.
催化反应完成后(起始α,β-不饱和吡唑酰胺为0.1mmol),往盛有3a反应液的试管中分别加入二甲基苯胺(0.08mmol)和甲醇(2.5mmol),在室温下搅拌过夜。柱层析分离纯化,利用高效液相色谱分析(3a:Daicel chiralcel IB,V正己烷:V异丙醇=90:10,流速1.0mL/min)、(3b:Daicel chiralcel IC,V正己烷:V异丙醇=95:5,流速0.8mL/min),得到(S)-5a,92%收率,98.6%ee。After completion of the catalytic reaction (starting α,β-unsaturated pyrazole amide is 0.1 mmol), dimethylaniline (0.08 mmol) and methanol (2.5 mmol) were separately added to the tube containing the 3a reaction solution at room temperature. Stir overnight. Separation and purification by column chromatography, and analyzed by high performance liquid chromatography (3a: Daicel chiralcel IB, V n-hexane : V isopropanol = 90:10, flow rate 1.0 mL/min), (3b: Daicel chiralcel IC, V -hexane : V isopropanol = 95:5, flow rate 0.8 mL/min) gave (S)-5a, 92% yield, 98.6% ee.
由于脂肪类的酯类化合物不便于检测和分离纯化,所以采取了分步的方式来完成酯化的过程:在反应容器中加入3t(46.2mg,0.173mmol,98%ee,),然后依次加入7.8mmol二氯 甲烷、DBU(0.1mmol)、甲醇(3.72mmol),室温下搅拌5h。柱层析分离纯化,利用高效液相色谱分析(Daicel chiralcel IE,V正己烷:V异丙醇=95:5,流速1.0mL/min),产物收率95%,对映体选择性98%ee。结果如下:Since the fatty ester compounds are not easy to detect and separate and purify, a stepwise process is carried out to complete the esterification process: 3t (46.2mg, 0.173mmol, 98% ee,) is added to the reaction vessel, and then added sequentially. 7.8 mmol of dichloromethane, DBU (0.1 mmol), methanol (3.72 mmol). Separation and purification by column chromatography, using high performance liquid chromatography (Daicel chiralcel IE, V n-hexane : V isopropanol = 95:5, flow rate 1.0 mL / min), product yield 95%, enantioselectivity 98% Ee. The results are as follows:
Figure PCTCN2015081341-appb-000025
Figure PCTCN2015081341-appb-000025
实施例8:普瑞巴林的合成Example 8: Synthesis of pregabalin
中国科学院成都有机化学有限公司公布了消旋的5c转化为消旋的6c的方法。他们用的是雷尼镍-H2作为氢化试剂对5c进行了还原关环,以97%的收率得到6c,虽然结果很好,但是操作复杂,并且过程中用到雷尼镍、氢气这些危险的试剂(CN 102115449A.06,07,2011)。Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, announced the conversion of racemic 5c to racemic 6c. They used Raney nickel-H 2 as a hydrogenating reagent to reduce and shut down 5c, and obtained 6c in 97% yield. Although the results were good, the operation was complicated, and Raney nickel and hydrogen were used in the process. Hazardous reagents (CN 102115449A.06, 07, 2011).
在这里我们提供了下列由5c合成6c的方法:该法反应条件温和、操作简单、反应高效Here we provide the following method for synthesizing 6c from 5c: the reaction conditions are mild, simple, and efficient.
Figure PCTCN2015081341-appb-000026
Figure PCTCN2015081341-appb-000026
在装有磁力搅拌装置的圆底烧瓶中,加入5c(68.82mg,0.34mmol)、NiCl2·6H2O(80.6mg,0.34mmol)、EtOH(33.9mmol),然后置于冰浴中5分钟,然后慢慢加入NaBH4(140.9mg,3.74mmol),反应溶液继续在冰浴下搅拌2小时。然后加入1mL乙醇淬灭反应,回到室温,往反应液中加入1mL 6mol/L的氢氧化钠溶液,继续搅拌1h。1h后,往反应液中加入2mol/L的盐酸溶液,调节PH值小于7,然后用二氯甲烷(4x 6mL)萃取,合并有机层,用无水硫酸钠干燥,接着抽滤旋干既得产物6c,收率:95%,利用高效液相色谱分析(Daicel chiralcel AD-H,V正己烷:V异丙醇=96:4,流速1.0mL/min),得到产物的对映选择性ee值97%。In a round bottom flask equipped with a magnetic stirrer, 5c (68.82 mg, 0.34 mmol), NiCl 2 ·6H 2 O (80.6 mg, 0.34 mmol), EtOH (33.9 mmol), and then placed in an ice bath for 5 minutes Then, NaBH 4 (140.9 mg, 3.74 mmol) was slowly added, and the reaction solution was further stirred under ice bath for 2 hr. Then, the reaction was quenched by adding 1 mL of ethanol, and returned to room temperature. 1 mL of a 6 mol/L sodium hydroxide solution was added to the reaction mixture, and stirring was continued for 1 hour. After 1 h, a 2 mol/L hydrochloric acid solution was added to the reaction solution to adjust the pH to less than 7, and then extracted with dichloromethane (4×6 mL), and the organic layer was combined, dried over anhydrous sodium sulfate, and then filtered and dried. 6c, yield: 95%, using high performance liquid chromatography (Daicel chiralcel AD-H, V n-hexane : V isopropanol = 96:4, flow rate 1.0 mL / min), the enantioselective ee value of the product was obtained. 97%.
化合物6c按照文献的报道(Tetrahedron,2011,67,636),在6mol/L盐酸中,100℃下回流10小时,便可以以95%的收率拿到普瑞巴林的盐酸盐并且ee值得到保持。 According to the literature report (Tetrahedron, 2011, 67, 636), in 6 mol/L hydrochloric acid, refluxing at 100 ° C for 10 hours, the salt of pregabalin can be obtained in 95% yield and the ee value is maintained. .

Claims (15)

  1. 一种不对称催化合成γ-硝基吡唑酰胺化合物的方法,其特征在于以硝基烷烃和α,β-不饱和吡唑酰胺为原料,手性氧化胺与稀土金属化合物形成的络合物为催化剂,
    Figure PCTCN2015081341-appb-100001
    分子筛为添加剂,反应后得到手性γ-硝基吡唑酰胺化合物,其中:
    A method for asymmetrically synthesizing a γ-nitropyrazole amide compound, characterized by using a nitroalkane and an α,β-unsaturated pyrazole amide as a raw material, a complex of a chiral amine oxide and a rare earth metal compound As a catalyst,
    Figure PCTCN2015081341-appb-100001
    The molecular sieve is an additive, and a chiral γ-nitropyrazole amide compound is obtained after the reaction, wherein:
    硝基烷烃的结构为RCH2NO2,R=H,CH3,Et,Bn;The structure of the nitroalkane is RCH2NO2, R=H, CH3, Et, Bn;
    α,β-不饱和吡唑酰胺化合物的结构为:The structure of the α,β-unsaturated pyrazole amide compound is:
    Figure PCTCN2015081341-appb-100002
    Figure PCTCN2015081341-appb-100002
    γ-硝基吡唑酰胺化合物具有如下结构:The γ-nitropyrazole amide compound has the following structure:
    Figure PCTCN2015081341-appb-100003
    Figure PCTCN2015081341-appb-100003
    手性氧化胺配体的结构为:The structure of the chiral amine oxide ligand is:
    Figure PCTCN2015081341-appb-100004
    Figure PCTCN2015081341-appb-100004
    其中R1=C6H5,4-FC6H4,4-ClC6H4,4-BrC6H4,4-MeC6H4,4-MeOC6H4,3-BrC6H4,3-MeC6H4,2-BrC6H4,2-MeOC6H4,3,4-Cl2C6H3,3,4-(MeO)2C6H3,2-Furyl,2-Thienyl,CH3,Pr,Pent,iBu,EtO,EtOOC;R2=CH3,Ph;R3=H,Cl,Br,I;Wherein R 1 =C 6 H 5 ,4-FC 6 H 4 ,4-ClC 6 H 4 ,4-BrC 6 H 4 ,4-MeC 6 H 4 ,4-MeOC 6 H 4 ,3-BrC 6 H 4 , 3-MeC 6 H 4 ,2-BrC 6 H 4 ,2-MeOC 6 H 4 ,3,4-Cl 2 C 6 H 3 ,3,4-(MeO) 2 C 6 H 3 ,2-Furyl, 2-Thienyl, CH 3 , Pr, Pent, i Bu, EtO, EtOOC; R 2 =CH 3 , Ph; R 3 =H, Cl, Br, I;
    n=1,2;R=Ph-,2,6-Me2C6H3-,2,6-Et2C6H3-,2,6-iPr2C6H3-,Ph2CH-;n=1,2; R=Ph-,2,6-Me2C6H3-,2,6-Et2C6H3-,2,6-iPr2C6H3-,Ph2CH-;
    稀土金属化合物为:三氟甲磺酸钆[Gd(OTf)3]、三氟甲磺酸钪[Sc(OTf)3]、三氟甲磺酸钬[Ho(OTf)3]、三氟甲磺酸镱[Yb(OTf)3]、三氟甲磺酸铒[Er(OTf)3]、三氟甲磺酸钇[Y(OTf)3]。The rare earth metal compound is: bismuth triflate [Gd(OTf) 3 ], bismuth triflate [Sc(OTf) 3 ], bismuth triflate [Ho(OTf) 3 ], trifluoromethyl ytterbium [Yb (OTf) 3], erbium trifluoromethanesulfonate [Er (OTf) 3], yttrium trifluoromethanesulfonate [Y (OTf) 3].
  2. 根据权利要求1所述的制备方法,在如下溶剂中进行反应:戊烷、己烷、二氯乙烷、氯仿、甲苯、乙苯、异丙苯、四氢呋喃、甲基叔丁基醚、2-甲基四氢呋喃、乙酸乙酯或乙酸异丙酯。The process according to claim 1, wherein the reaction is carried out in the following solvents: pentane, hexane, dichloroethane, chloroform, toluene, ethylbenzene, cumene, tetrahydrofuran, methyl t-butyl ether, 2- Methyltetrahydrofuran, ethyl acetate or isopropyl acetate.
  3. 根据权利要求1所述的制备方法,反应温度为25-50℃。The process according to claim 1, wherein the reaction temperature is 25 to 50 °C.
  4. 根据权利要求1所述的制备方法,其特征在于以硝基烷烃和α,β-不饱和吡唑酰胺为原料,手性氧化胺与稀土金属化合物形成的络合物为催化剂,
    Figure PCTCN2015081341-appb-100005
    分子筛为添加剂,二氯甲烷为溶剂,于25-50℃,常压下反应12-120h,得手性γ-硝基吡唑酰胺化合物。
    The preparation method according to claim 1, characterized in that a complex of a chiral amine oxide and a rare earth metal compound is used as a catalyst, and a nitroalkane and an α,β-unsaturated pyrazole amide are used as a raw material.
    Figure PCTCN2015081341-appb-100005
    The molecular sieve is an additive, dichloromethane is used as a solvent, and the reaction is carried out at 25-50 ° C under normal pressure for 12-120 h to obtain a chiral γ-nitropyrazole amide compound.
  5. 根据权利要求1或4所述的制备方法,硝基烷烃与α,β-不饱和吡唑酰胺化合物的摩尔比是1.86:1-55.8:1。The process according to claim 1 or 4, wherein the molar ratio of the nitroalkane to the α,β-unsaturated pyrazole amide compound is 1.86:1-55.8:1.
  6. 根据权利要求5所示的制备方法,硝基烷烃与α,β-不饱和吡唑酰胺化合物的摩尔比是9.3:1。According to the production method of claim 5, the molar ratio of the nitroalkane to the α,β-unsaturated pyrazole amide compound is 9.3:1.
  7. 根据权利要求1或4所述的制备方法,所述手性氧化胺与稀土金属化合物的摩尔比为0.8:1.0-1.5:1.0。The process according to claim 1 or 4, wherein the molar ratio of the chiral amine oxide to the rare earth metal compound is from 0.8:1.0 to 1.5:1.0.
  8. 根据权利要求7所述的制备方法,所述手性氧化胺与稀土金属化合物的摩尔比为1.2:1.0。The process according to claim 7, wherein the molar ratio of the chiral amine oxide to the rare earth metal compound is 1.2:1.0.
  9. 根据权利要求1或4所述的制备方法,所述
    Figure PCTCN2015081341-appb-100006
    分子筛的量为:0.1mmol的α,β-不饱和吡唑酰胺需
    Figure PCTCN2015081341-appb-100007
    分子筛为10-100mg。
    The preparation method according to claim 1 or 4, wherein said
    Figure PCTCN2015081341-appb-100006
    The amount of molecular sieve is: 0.1mmol of α,β-unsaturated pyrazole amide
    Figure PCTCN2015081341-appb-100007
    The molecular sieve is 10-100 mg.
  10. 根据权利要求1或4所述的制备方法,所述的稀土金属化合物是三氟甲磺酸钆[Gd(OTf)3]。The method according to claim 1 or 4, wherein the rare earth metal compound is lanthanum triflate [Gd(OTf)3].
  11. 根据权利要求1或4所述的制备方法,所述的手性氧化胺配体中n=2,R=2,6-iPr2C6H3-。The process according to claim 1 or 4, wherein the chiral amine oxide ligand has n = 2, R = 2,6-iPr2C6H3-.
  12. 根据权利要求1或4所述的制备方法,所述的α,β-不饱和吡唑酰胺化合物与稀土金属化合物的摩尔比为20:1-10:1。The process according to claim 1 or 4, wherein the molar ratio of the α,β-unsaturated pyrazole amide compound to the rare earth metal compound is from 20:1 to 10:1.
  13. 根据权利要求1或4所述的制备方法,其特征在于0.1mmolα,β-不饱和吡唑酰胺化合物需要
    Figure PCTCN2015081341-appb-100008
    分子筛30-100mg。
    The production method according to claim 1 or 4, characterized in that 0.1 mmol of α,β-unsaturated pyrazole amide compound is required
    Figure PCTCN2015081341-appb-100008
    Molecular sieve 30-100mg.
  14. 根据权利要求1~4任一权利要求所述的制备方法,进一步地包括如下步骤:The preparation method according to any one of claims 1 to 4, further comprising the following steps:
    γ-硝基吡唑酰胺化合物在有机碱存在下与甲醇反应得到酯化产物;The γ-nitropyrazole amide compound is reacted with methanol in the presence of an organic base to obtain an esterified product;
    所述的酯化产物具有如下结构:The esterification product has the following structure:
    Figure PCTCN2015081341-appb-100009
    Figure PCTCN2015081341-appb-100009
    其中R,R1的定义与权利要求1相同。Wherein R, R 1 has the same definition as in claim 1.
  15. 根据权利要求10所示的制备方法,所述有机碱选自三乙胺,二异丙基乙胺,三甲胺,三正丙胺,三正丁胺,二甲基苯胺,二乙基苯胺,二甲基苄胺,二乙基苄胺或1,8-二氮杂环[5,4,0]十一烯-7。 The process according to claim 10, wherein the organic base is selected from the group consisting of triethylamine, diisopropylethylamine, trimethylamine, tri-n-propylamine, tri-n-butylamine, dimethylaniline, diethylaniline, and Methylbenzylamine, diethylbenzylamine or 1,8-diazacyclo[5,4,0]undecene-7.
PCT/CN2015/081341 2014-09-22 2015-06-12 Method for asymmetrically catalyzed synthesis of nitropyrazole amide compound WO2016045415A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP15844037.0A EP3199525A4 (en) 2014-09-22 2015-06-12 Method for asymmetrically catalyzed synthesis of nitropyrazole amide compound
JP2017512956A JP2017530956A (en) 2014-09-22 2015-06-12 Asymmetric catalytic synthesis of nitropyrazole amide compounds
US15/511,243 US10464899B2 (en) 2014-09-22 2015-06-12 Asymmetrically catalyzed synthesis method of nitropyrazole amide compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201410486209.3 2014-09-22
CN201410486209.3A CN104262255A (en) 2014-09-22 2014-09-22 Method for asymmetric catalytic synthesis of gamma-nitropyrazole amide compound
CN201510075076.5A CN105985292B (en) 2014-09-22 2015-02-12 A kind of asymmetry catalysis synthesis γ-nitropyrazole amide compound method
CN201510075076.5 2015-02-12

Publications (1)

Publication Number Publication Date
WO2016045415A1 true WO2016045415A1 (en) 2016-03-31

Family

ID=55580257

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/081341 WO2016045415A1 (en) 2014-09-22 2015-06-12 Method for asymmetrically catalyzed synthesis of nitropyrazole amide compound

Country Status (1)

Country Link
WO (1) WO2016045415A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110508323A (en) * 2019-09-04 2019-11-29 湖北工程学院 Method based on temperature sensitive type chiral amino acid copper complex catalyst aqueous catalysis Henry asymmetric reduction reaction

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102531815A (en) * 2011-12-22 2012-07-04 四川大学 Method for asymmetric catalyzing epoxidation reaction of alpha, beta-unsaturated carbonyl compounds
CN104262255A (en) * 2014-09-22 2015-01-07 四川大学 Method for asymmetric catalytic synthesis of gamma-nitropyrazole amide compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102531815A (en) * 2011-12-22 2012-07-04 四川大学 Method for asymmetric catalyzing epoxidation reaction of alpha, beta-unsaturated carbonyl compounds
CN104262255A (en) * 2014-09-22 2015-01-07 四川大学 Method for asymmetric catalytic synthesis of gamma-nitropyrazole amide compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MASAYUKI, H. ET AL.: "Molecular Sieves 4A Work to Mediate the Satalytic Metal Enolization of Nucleophile Precursors: Application to Catalyzed Enantioselective Michael Addition Reactions", TETRAHEDRON LETTERS, vol. 49, no. 35, 14 June 2008 (2008-06-14), pages 5220, XP022852745, DOI: doi:10.1016/j.tetlet.2008.05.156 *
See also references of EP3199525A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110508323A (en) * 2019-09-04 2019-11-29 湖北工程学院 Method based on temperature sensitive type chiral amino acid copper complex catalyst aqueous catalysis Henry asymmetric reduction reaction
CN110508323B (en) * 2019-09-04 2022-06-07 湖北工程学院 Method for water-phase catalysis Henry asymmetric addition reaction based on temperature-sensitive chiral copper amino acid complex catalyst

Similar Documents

Publication Publication Date Title
Hamashima et al. Highly enantioselective fluorination reactions of β-ketoesters and β-ketophosphonates catalyzed by chiral palladium complexes
CN110117260B (en) Preparation method of 3-alkyl quinoxaline-2 (1H) -ketone compound
Yadav et al. Aza-Michael reactions in ionic liquids. a facile synthesis of β-amino compounds
CN111777477B (en) Method for synthesizing succinic acid derivative or 3-aryl propionic acid
CN109734600B (en) Synthesis method of chiral beta-hydroxy acid ester compound
JP2017530956A (en) Asymmetric catalytic synthesis of nitropyrazole amide compounds
JP4015450B2 (en) Method for producing optically active alcohol
Wang et al. Synthesis of chiral allylic phosphonates via asymmetric reductive cross-coupling of α-bromophosphonates and vinyl bromides
WO2016045415A1 (en) Method for asymmetrically catalyzed synthesis of nitropyrazole amide compound
US6620954B1 (en) Phosphinometallocenylamides as novel ligands for asymmetric catalysis
CN113200856B (en) Trifluoromethyl propylene compound and preparation method and application thereof
CN114644662A (en) Chiral phosphine nitrogen tridentate ligand based on ferrocene structure and application thereof
Saidalimu et al. Activation of Trifluoromethylthio Moiety by Appending Iodonium Ylide under Copper Catalysis for Electrophilic Trifluoromethylation Reaction
CN109970560A (en) Preparation method of tri-substituted 1, 3-diene compound
CN102108043B (en) Synthesis method of 1,3,5,7-tetrahydroxyadamantane
WO2020220651A1 (en) Method for synthesizing chiral 2-hydroxy-1,4-dicarbonyl compound and pantolactone
Mori et al. Diastereo-differentiating intramolecular cyclopropanations of prochiral olefins and a diazo ester linked by optically active 2, 4-pentanediol
CN109400493A (en) Sha Ku is than bent and its intermediate preparation method
CN113754597B (en) Benzhydryl piperazine compound containing linear olefin and preparation method thereof
CN105820096B (en) A kind of method for preparing substitution ethyl aryl sulfone
CN110683949B (en) Method for preparing 9, 10-phenanthrene dicarboxylic ester compound
WO2023097691A1 (en) Method for obtaining high-selectivity b-chiral branched-chain chiral amino acid
EP2327685B1 (en) Process for production of alpha-trifluoromethyl- beta-substituted- beta -amino acid
CN115490592A (en) Method for constructing 1, 4-diene drug molecular skeleton
CN114516796A (en) Method for preparing 5-oxohexanoate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15844037

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017512956

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 15511243

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2015844037

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015844037

Country of ref document: EP